113 related articles for article (PubMed ID: 22492986)
1. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy.
Johnson EO; Chang KH; Ghosh S; Venkatesh C; Giger K; Low PS; Shah K
J Cell Sci; 2012 Mar; 125(Pt 5):1204-16. PubMed ID: 22492986
[TBL] [Abstract][Full Text] [Related]
2. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
Johnson EO; Chang KH; de Pablo Y; Ghosh S; Mehta R; Badve S; Shah K
J Cell Sci; 2011 Aug; 124(Pt 16):2711-22. PubMed ID: 21807936
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.
Long M; Yin G; Liu L; Lin F; Wang X; Ren J; Wei J; Dong K; Zhang H
Cancer Gene Ther; 2012 Apr; 19(4):271-81. PubMed ID: 22281755
[TBL] [Abstract][Full Text] [Related]
4. Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.
Yoon MJ; Park SS; Kang YJ; Kim IY; Lee JA; Lee JS; Kim EG; Lee CW; Choi KS
Carcinogenesis; 2012 Mar; 33(3):492-500. PubMed ID: 22159225
[TBL] [Abstract][Full Text] [Related]
5. LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs.
Po'uha ST; Shum MS; Goebel A; Bernard O; Kavallaris M
Oncogene; 2010 Jan; 29(4):597-607. PubMed ID: 19881550
[TBL] [Abstract][Full Text] [Related]
6. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
Katayama H; Sasai K; Czerniak BA; Carter JL; Sen S
J Cell Biochem; 2007 Dec; 102(5):1318-31. PubMed ID: 17957726
[TBL] [Abstract][Full Text] [Related]
7. Impaired spermatogenic ability of testicular germ cells in mice deficient in the LIM-kinase 2 gene.
Takahashi H; Koshimizu U; Miyazaki J; Nakamura T
Dev Biol; 2002 Jan; 241(2):259-72. PubMed ID: 11784110
[TBL] [Abstract][Full Text] [Related]
8. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway.
Wang LH; Xiang J; Yan M; Zhang Y; Zhao Y; Yue CF; Xu J; Zheng FM; Chen JN; Kang Z; Chen TS; Xing D; Liu Q
Cancer Res; 2010 Nov; 70(22):9118-28. PubMed ID: 21045147
[TBL] [Abstract][Full Text] [Related]
9. LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators.
Manetti F
Med Res Rev; 2012 Sep; 32(5):968-98. PubMed ID: 22886629
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of nuclear accumulated Aurora-A.
Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
[TBL] [Abstract][Full Text] [Related]
11. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo.
Huck JJ; Zhang M; McDonald A; Bowman D; Hoar KM; Stringer B; Ecsedy J; Manfredi MG; Hyer ML
Mol Cancer Res; 2010 Mar; 8(3):373-84. PubMed ID: 20197380
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
[TBL] [Abstract][Full Text] [Related]
13. Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer.
Qu Y; Zhang L; Mao M; Zhao F; Huang X; Yang C; Xiong Y; Mu D
Cancer Gene Ther; 2008 Aug; 15(8):517-25. PubMed ID: 18404163
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
[TBL] [Abstract][Full Text] [Related]
16. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
Fielding AB; Lim S; Montgomery K; Dobreva I; Dedhar S
Oncogene; 2011 Feb; 30(5):521-34. PubMed ID: 20838383
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer.
Nikhil K; Haymour HS; Kamra M; Shah K
Br J Cancer; 2021 Mar; 124(5):995-1008. PubMed ID: 33311589
[TBL] [Abstract][Full Text] [Related]
18. Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition.
Sumi T; Hashigasako A; Matsumoto K; Nakamura T
Exp Cell Res; 2006 Apr; 312(7):1021-30. PubMed ID: 16455074
[TBL] [Abstract][Full Text] [Related]
19. Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.
LeRoy PJ; Hunter JJ; Hoar KM; Burke KE; Shinde V; Ruan J; Bowman D; Galvin K; Ecsedy JA
Cancer Res; 2007 Jun; 67(11):5362-70. PubMed ID: 17545617
[TBL] [Abstract][Full Text] [Related]
20. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
Vlecken DH; Bagowski CP
Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
